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As a milestone breakthrough of stem cell and regenerative medicine in recent years, somatic cell reprogramming has opened up new 
applications of regenerative medicine by breaking through the ethical shackles of embryonic stem cells. However, induced pluripo-
tent stem (iPS) cells are prepared with a complicated protocol that results in a low reprogramming rate. To obtain differentiated target 
cells, iPS cells and embryonic stem cells still need to be induced using step-by-step procedures. The safety of induced target cells 
from iPS cells is currently a further concerning matter. More broadly conceived is lineage reprogramming that has been investigated 
since 1987. Adult stem cell plasticity, which triggered interest in stem cell research at the end of the last century, can also be included 
in the scope of lineage reprogramming. With the promotion of iPS cell research, lineage reprogramming is now considered as one of 
the most promising fields in regenerative medicine, will hopefully lead to customized, personalized therapeutic options for patients in 
the future. 
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The word “programme” stands for a list of instructions 
written in a programming language, which controls the be-
havior of a machine or computer. The programming lan-
guage is known as a computer language for computers, 
while in cells, it is an epigenetic language in which pro-
gramme means a series of normal developmental and dif-
ferentiation processes arranged in an orderly manner. “Re-
programme” is the reversal of programming. It refers to 
erasure and remodeling of the functional state of the ge-
nome, resulting in conversion of a differentiated cell to an 
immature cell. Reprogramming can be divided into two 
types: pluripotent and lineage reprogramming. Of the two, 
the former includes nuclear transfer, cell fusion, iPS cell 
reprogramming and long-term in vitro cell culture [1]. The 
latter refers to directly converting specialized cells (or pro-
genitor cells) from one lineage to another without conver-
sion to the iPS cell stage, including transdifferentiation, 
dedifferentiation, transdetermination, and metaplasia [2]. 
In the review of the history of reprogramming, we found 
that the development of lineage reprogramming occurred 
earlier than iPS cell establishment in 2006 [3]. In 1987, Da-
vis et al. successfully reprogrammed fibroblasts to muscle 
cells by forced expression of the transcription factor MyoD 
[4]. In 2004, Xie et al. achieved reprogramming of B cells 
into macrophages by forced expression of the transcription 
factor C/EBPα [5]. In an interview after winning the Nobel 
Prize, Yamanaka said that he was inspired by the discovery 
of Davis in 1987. Therefore, the studies of lineage repro-
gramming laid the foundation for the emergence of iPS cells. 
This article will systematically review the research progress 
of lineage reprogramming since 1999 when Petersen et al. 
reported a bone marrow source of hepatocytes [6]. 
1  Transdifferentiation 
Transdifferentiation refers to direct fate switching between  
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two distinct cell types without passing through the pluripo-
tency stage, which is also called lineage switching or line-
age conversion [7]. 
Studies of adult stem cell plasticity, including bone mar-
row-derived hematopoietic stem cells (HSCs) and mesen-
chymal stem cells (MSCs), brought about worldwide enthu-
siasm for stem cells in biological and medical fields. As the 
first well studied and recognized stem cell types, HSCs had 
been the focus of most research concerning adult stem cell 
plasticity. In addition to hematopoietic reconstitution and a 
tri-lineage differentiation potential including osteoblasts, 
adipocytes and chondroblasts, many studies have demon-
strated that HSCs and MSCs can be induced into various 
types of functional cells including hepatocytes, skeletal 
muscle cells, cardiac cells, endothelial cells, and neural cells 
[8,9]. 
During this time, most researchers hypothesized a 
mechanism of “transdifferentiation”. It should be noted that 
the concept of “transdifferentiation”, in which the cells are 
adult stem cells rather than differentiated cells, is different 
from transdifferentiation described in this review. Here, we 
categorize “transdifferentiation” into transdetermination that 
will be discussed in detail below. 
Since 2006, transdifferentiation strategy-based cell con-
versions from one mature cell type to another target cell 
type have been achieved by forced expression of transcrip-
tion factors essential for development of the lineage (Table 
1). Such achievements have been extended from neural cells 
to other tissues including blood, heart, and liver. Fibroblasts 
have been used as starting cells in most of the studies, be-
cause of their accessibility. Several conclusions can be 
drawn from Table 1: (i) In principle, transdifferentiation is 
easier between two closely related cell types than it is for 
more distantly related cell types. For example, only a single 
transcription factor (C/EBPα or C/EBPβ) is needed for cell 
conversion from B cells to macrophages [5], whereas both 
PU.1 and C/EBPα are necessary for conversion of fibro-
blasts to macrophages [10]. (ii) Transdifferentiation is easier 
in mouse cells than that in human cells in terms of conver-
sion efficiency and the required number of transcription 
factors. For example, only three transcription factors (Ascl1, 
Brn2, and Myt1l) are needed for cell conversion from fibro-
blasts to neural cells [13], whereas the same conversion in 
human cells is unsuccessful without the addition of another 
transcription factor, namely NeuroD1 [14], or one of Lmx1a 
and FoxA2 [15]. 
Most of the starting cell types and associated final target 
cell types in transdifferentiation originate from the same 
germ layer summarized in Table 1. Based on the same 
strategy, transdifferentiation has achieved conversion of 
fibroblasts to hepatocytes [18,19], and hepatocytes to neural 
cells [20], which are the most clear transdifferentiation 
events that cross germ layers. These findings are advancing 
the success of regenerative medicine. 
Table 1  Transdifferentiationa) 
Starting cells Final cells Strategy Efficiency Species Reference 
B cells macrophage retroviral OE of C/EBPα or C/EBPβ 30% mouse [5] 
NIH-3T3, embryonic/ 
adult skin fibroblasts 
macrophage retroviral OE of PU.1 and C/EBPα 36.30% mouse [10] 
noncardiogenic meso-
derm, extraembryonic 
mesoderm of the  
amnion 
cardiomyocytes 
transiently transfected cultured mouse em-
bryos with Gata4, Tbx5, Baf60c OE 
9/16 embryo mouse [11] 




retrovirus or lentivirus OE of Gata4, Mef2c, 
Tbx5 
20.60% mouse [12] 
embryonic and post- 
natal fibroblasts 
functional neurons lentivirus OE of Ascl1, Brn2, Myt1l 5.83% mouse [13] 
fetal fibroblasts functional neurons 
lentivirus OE of Ascl1, Brn2, Myt1l, Neu-
roD1 
2%–4% human [14] 
fibroblasts dopaminergic neurons 
lentivirus OE of Ascl1, Brn2, Myt1l, Lmx1a, 
FoxA2 
16% ± 4.3% human [15] 
embryonic fibroblasts 
self-renewing, tripotent 
neural precursor cells 
lentivirus OE of Brn2, Sox2, FoxG1 11.50% mouse [16] 




lentivirus OE of Mash1, Ngn2, Sox2, Nurr1, 
and Pitx3 
1%–2% human [17] 
tail-tip fibroblasts 
functional hepatocyte- 
like cells, can be 
proliferated 
lentivirus OE of Gata4, Hnf1a, Foxa3, and 
knockout of p19Arf 





embryonic and adult 
fibroblasts 
closely resemble 
hepatocytes in vitro 
retrovirus OE, three specific combinations of 
two transcription factors, comprising Hnf4a 
plus Foxa1, Foxa2 or Foxa3 




doxycycline (dox)-inducible lentiviruses 
containing the cDNAs of Ascl1 (A), Brn2 (B), 
and Myt1l (M) in various combinations 
12.50% mouse [20] 
a) ND, not detected; OE, overexpression.  
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2  Dedifferentiation 
Dedifferentiation is the reversion of differentiated cells to a 
less differentiated state with loss of specialized cell func-
tions and structures, which can be differentiated into other 
cell types. Induced conversion of somatic cells to pluripo-
tent stem cells (i.e., iPS cells) can be considered as the most 
typical example. The majority of dedifferentiation-based 
strategies of lineage reprogramming are cell conversions of 
mature cells to unipotent or multipotent stem cells, which 
has been achieved with blood, cardiac and neural cells as 
well as melanocytes (Table 2). 
iPS reprogramming factors are mostly used to induce 
starting cells into an unstable intermediate population [25] 
that can be differentiated into target cells by external cues 
such as specific growth factors. The use and combinations 
of iPS reprogramming factors are not the same for distinct 
target cells. For example, forced expression of a single 
transcription factor, Oct-4, allows the generation of an in-
termediate population that gives rise to blood lineages [22], 
whereas at least three factors including Oct-4, which is in-
dispensable, are required for cell conversion to cardiac and 
neural cells [24,25]. However, Their et al. [26] reported that 
constitutive induction of Sox2, Klf4, and c-Myc while 
strictly limiting Oct-4 activity to the initial phase of repro-
gramming allows the generation of stably expandable neural 
stem cells (NSCs). Because Sox2, Klf4, and c-Myc are en-
dogenous transcription factors in NSCs, their expression is 
not limited during lineage reprogramming. Another study 
reported that transient induction of the four reprogramming 
factors (Oct-4, Sox2, Klf4, and c-Myc) could efficiently 
convert fibroblasts to functional neural stem/progenitor cells 
[25]. These observations indicate that exogenous expression 
of iPS cell reprogramming factors must be controlled for the 
production of stably expandable target cells.  
Interestingly, adult hematopoietic programs are activated 
in CD45+ fibroblasts overexpressing Oct-4 [22]. Erythro-
poietin-treated CD45+ fibroblasts overexpressing Oct-4 
generate erythroid cells expressing adult β-globin protein 
rather than embryonic ζ-globin [22] that is always activated 
in embryonic hematopoietic programs. Ectopic expression 
of Lin28 reprograms hematopoietic stem/progenitor cells 
obtained from adult bone marrow to mediate multilineage 
reconstitution that resembles fetal lymphopoiesis including 
increased development of B-1a, marginal zone B, gam-
ma/delta T cells, and natural killer T cells [23]. Although 
these two studies are not comparable because of distinct 
species, starting cells, and transcription factors, it can be 
concluded that such a route of dedifferentiation may not be 
the only one. 
It is noteworthy that both transdifferentiation and dedif-
ferentiation strategies enable the expansion and/or 
self-renewal of target cells [16,18,25,26]. A typical example 
includes the work by Their et al. [26]. They generated neu-
rosphere-like colonies that can be expanded for more than 
50 passages, which may facilitate potential applications in 
regenerative medicine.  
3  Transdetermination 
Transdetermination refers to reprogramming of a committed 
but not yet fully differentiated cell type into another [7]. The 
adult stem cell plasticity of HSCs and MSCs can be catego- 
Table 2  Dedifferentiationa) 
Starting cells Final cells Strategy Efficiency Species Reference 
mature B cells T cells 
by dedifferentiation to uncommitted progeni-
tors in conditional Pax5 deletion mice model 





addition of hematopoietic growth factors 21 
days after lentivirus OE of Oct-4 under iPS 
conditions 
7.5%–56.1% human [22] 
adult bone marrow 
LSK+ HS/PCs 
accquired the ability of 
fetal lymphopoiesis 
retrovirus OE of Lin28 ND mouse [23] 
embryonic fibroblasts cardiomyocytes 
retrovirus or transient OE of Oct4, Sox2, Klf4, 
c-Myc (dispensable), adding JAK inhibitor and 
BMP4 4-9 days after culture under iPS condi-
tions 
40% mouse [24] 
embryonic fibroblasts, 




transient OE of the four reprogramming factors 
(Oct4, Sox2, Klf4, and c-Myc), reprogrmming 
for two steps (4 days under iPS condi-









nies, expanded for more 
than 50 passages 
constitutively inducing Sox2, Klf4, and c-Myc 
while strictly limiting Oct4 activity to the initial 
phase of reprogramming (curtailed 
reprogramming) 





neural crest (NC) 
stem-like cells 
forced expression of the intracellular domain of 
Notch1 (NIC1) alone 
30% human [27] 
a) ND, not detected; OE, overexpression. 
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rized under transdetermination. For example, Jang et al. [28] 
isolated a small Fr25lin− HSC population from adult mouse 
bone marrow. RT-PCR analysis demonstrated that hepato-
cyte-specific marker genes were induced at 48 h after indi-
rect coculture of Fr25lin− populations with injured minced 
liver tissues, and coculture with normal liver tissues or cul-
ture alone were the controls. Our laboratory [29] previously 
isolated a subset of umbilical cord blood-derived β2m−c- 
Met+ cells that display some morphological characteristics 
of hepatocytes after indirect coculture with transgenic he-
patic stellate cells. Several hepatocyte-specific genes are 
also expressed at mRNA and protein levels. In addition, the 
induced cells display liver-specific functions. These results 
suggest that a subset of umbilical cord blood cells can be 
transdeterminated into hepatocyte-like cells under indirect 
coculture conditions. We also showed that approximately 
70% of the MSCs from human umbilical cord blood exhibit 
a typical neuron-like phenotype in vitro when provided with 
suitable external clues [30]. 
In subsequent studies, researchers reported that cell fu-
sion might be the principal mechanism of adult stem cell 
plasticity. Cell fusion is a cellular combination of donor 
blood cells with host cells to produce heterokaryons with a 
hybrid or mixed phenotype. Cell fusion has been confirmed 
in a liver transplantation model under normal and patholog-
ical conditions, which exhibits a frequency between 1/104 
and 1/106. Wang et al. [31] and Vassilopoulos et al. [32] first 
detected these hybrid cells in FAH–/– mice. It has been es-
tablished that myelomonocytic cells are the major source of 
hepatocyte fusion partners. However, Tanabe et al. [33] de-
tected hepatocyte-like cells with mouse and human chro-
mosomes, and cells with only human chromosomes in re-
ceipt mice transplanted with human cord blood cells. These 
studies demonstrate that both cell fusion and transdetermi-
nation may be the mechanisms for human cord blood 
cell-derived hepatocyte-like cells in transplanted mouse 
models. 
However, the limited knowledge of external cues in 
transdetermination hinders the clinical potential of regener-
ative medicine, resulting in the low frequency of emerging 
target cells after growth factor induction in vitro or trans-
plantation into an animal model of injury in vivo. Therefore, 
we have performed genetic manipulation of adult stem cells 
by a transcription factor-based transdetermination strategy. 
For example, such an approach can promote neural differ-
entiation of human bone marrow MSCs by overexpression 
of brain-derived neurotrophic factor [34] or knockdown of 
neuron-restrictive silencer factor (NRSF) [35]. Moreover, 
pancreatic differentiation is enhanced by overexpression of 
pancreatic and duodenal homeobox 1 in human bone mar-
row MSCs [36] or knockdown of NRSF in human amniotic 
fluid-derived stem cells [37]. Interestingly, the same genetic 
modification with one transcription factor (NRSF) will 
trigger distinct cell conversion in human bone marrow 
MSCs and human amniotic fluid-derived stem cells, sug-
gesting that the developmental stage of starting cells is in-
volved in determination of cell reprogramming. 
4  Physiological and pathogenic cell conversions 
Metaplasia refers to more general transformation of one 
tissue type into another, which is usually stimulated by 
chronic inflammation [7,38]. It often involves the transfor-
mation of undifferentiated stem or progenitor cells into an-
other cell type that is similar in nature. Common examples 
of metaplasia include squamous, intestinal and mesenchy-
mal metaplasia. 
Another common example of cell conversion is epithelial 
to mesenchymal transition (EMT). It is activated by the ex-
pression of important inducers of EMT, including transcrip-
tion factors Snail, Slug and Twist in epithelial cells, result-
ing in changes of the cellular behavior. During the EMT 
process, the expression of E-cadherin and other epithelial 
cell markers is downregulated, while the expression of 
mesenchymal cell markers including N-cadherin, vimentin 
and α-smooth muscle actin is upregulated. The epithelial 
cells adopt a mesenchymal cell phenotype in appearance 
and acquire motility as well as invasive properties. A rever-
sal of EMT process is mesenchymal-epithelial transition 
(i.e., MET). EMT-MET plasticity plays an important role in 
embryonic development, iPS cell reprogramming, and tu-
mor progression [3941]. It is certain that new physiological 
and pathogenic cell conversions will be discovered with the 
development of lineage tracing technology. The differences 
between the several types of cell conversions mentioned 
above are listed in Figure 1. 
5  Application prospects of lineage reprogram-
ming 
Thus far, the strategy for lineage reprogramming has pre-
dominantly been forced expression of transcription factors. 
However, cell conversion from fibroblasts to neural cells 
has been reported by ectopic expression of microRNAs in-
cluding miR-9/9* and miR-124 [42], but at a low rate of 
conversion. This process is facilitated by NeuroD2 overex-
pression and the addition of neurogenic transcription factors 
Ascl1 and Myt1l. It is unknown whether the effects of in-
teractions in the network of miRNA-target genes on repro-
gramming can be controlled or predicted. 
In terms of application, the use of small molecules may 
be a good choice, which will facilitate the emergence of 
clinical applications. For example, during dedifferentiation, 
the addition of a JAK inhibitor can inhibit long-term ex-
pression of exogenous transcription factors including Oct-4, 
Sox2, Klf4 and c-Myc, which will block further dedifferen-
tiation from an unstable intermediate to an iPS cell [24]. 
Small molecules have an enormous potential to facilitate the  
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Figure 1  A simplified schematic of lineage reprogramming strategies. 1, transdifferentiation; 2, dedifferentiation; 3, transdetermination; 4, metaplasia. 
Transdifferentiation is cell conversion between differentiated cells originating from the same or different germ layers. In dedifferentiation, cells are convert-
ed into stem cells at different developmental stages in addition to pluripotent stem cells. The starting cells can also be stem cells (except pluripotent stem 
cells) in addition to differentiated cells. Transdifferentiation can also occur between the same or different germ layers. Metaplasia is transformation between 
tissue-specific stem cells under pathological conditions. 
application of lineage reprogramming. Thus far, a growing 
number of small molecules have proved to be efficient and 
safe in reprogramming [43]. Perhaps several lineage-   
reprogramming cocktails of small molecules suitable for 
different target cells will be developed in the near future. 
Genetic manipulation involves overexpression, knockdown 
[18] or knockout [21] strategies. In most studies, transfec-
tion of transcription factors uses viral vectors that have 
safety concerns, as is the case with iPS cells. Thus, it is of 
crucial importance to reprogramme fibroblasts to NSCs by 
transient overexpression of Oct-4, Sox2, Klf4 and c-Myc 
[25], and mouse mesoderm to heart tissues by transient 
overexpression of Gata4, Tbx5, and Baf60c [11]. Transient 
expression of lineage reprogramming factors to achieve a 
full phenotypic switch is one of the most promising strate-
gies in stem cell and regenerative medicine translational 
research. 
A comparison of the lineage and iPS cell reprogramming 
strategies is listed in Table 3. In Table 3, limited cell scaling 
is in contrast to the near unlimited capacity for expansion of 
iPS/embryonic stem cells. In fact, lineage reprogram-
ming-derived expandable NSCs and proliferating hepato-
cytes have been achieved recently [18,25,26]. In addition, in 
vivo regeneration has been described in a report by Zhou et 
al. [45]. Adenoviral vectors encoding a specific combina-
tion of three transcription factors, Ngn3, Pdx1 and Mafa, 
were delivered into the differentiated pancreatic exocrine 
cells of adult mice of which 2/3 were infected successfully 
after one month. About 20% of the infected cells were re-
programmed into insulin-secreting cells that closely resem-
bled β-cells. Such an approach can be considered as in vivo 
lineage reprogramming and a new type of gene therapy. In 
terms of the tumor risk, it is low for lineage reprogramming 
without reversion to a pluripotent stem cell state. Notably, it 
is important to precisely control the time point when unsta-
ble intermediates in dedifferentiation strategy are emerging. 
Further research is still needed to elucidate new transcrip-
tion factors, cell conversion strategies, and the underlying 
mechanisms of lineage reprogramming. 
In summary, compared with studies of adult stem cell 
plasticity, lineage-reprogramming research has made great 
progress. Specifically, the cell conversion efficiency has 
been greatly increased, and reprogrammed cells can be ex-
panded. These achievements establish the clinical founda-
tion for lineage reprogramming in regenerative medicine. 
In the near future, for a bedridden patient, it may be rou-
tine to take a skin sample to culture fibroblasts under stand-
ard conditions, and a reprogramming kit will be used to 
reprogramme the fibroblasts into expandable stem/progen- 
itor cells that will be injected to regenerate the injured tis-
sues of the patient. Perhaps this procedure will become rou-
tine work for a department of stem cell and regenerative 
medicine in a hospital. The customized and individualized 
clinical applications of reprogrammed stem/progenitor cells 
are the most attractive to researchers and patients in regen-
erative medicine. 
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